INTS: Intensity Therapeutics Inc

INTS News

• 12:27 Benchmark lowers Intensity Therapeutics stock price target to $1.50 on dilution
• 20:03 Brookline Capital upgrades Intensity Therapeutics stock rating to Buy
• 11:54 Intensity Therapeutics regains compliance with Nasdaq listing requirements
• 21:36 Intensity Therapeutics shareholders elect director and approve auditor at annual meeting
• 14:08 Intensity Therapeutics, Inc. Announces that INT230-6 Achieved 100% Complete Response Rate in Preclinical Models of Malignant Peripheral Nerve Sheath Tumors (MPNST)
• 20:30 U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.24%
• 16:27 Morning News Wrap-Up: Thursday’s Biggest Stock Market Stories - TipRanks.com
• 16:07 Nasdaq Moves Higher; Oracle Shares Jump After Upbeat Q4 Results - CureVac (NASDAQ:CVAC), Helius Medical Tech (NASDAQ:HSDT)
• 14:32 Dow Tumbles Over 100 Points; US Producer Prices Edge Higher In May - Healthcare Triangle (NASDAQ:HCTI), Greenlane Hldgs (NASDAQ:GNLN)
• 03:56 Intensity Therapeutics, Inc. Announces Pricing of Public Offering
• 20:13 Intensity Therapeutics announces public offering of common stock
• 12:37 Intensity’s cancer drug shows tumor necrosis in early-stage study
• 12:32 Intensity Therapeutics, Inc.’s Phase 3 INVINCIBLE-3 Sarcoma Study Selected for Presentation at the American Society of Clinical Oncology (ASCO) 2025 Annual Meeting
• 12:28 Intensity Therapeutics, Inc. to Collaborate with Author, Model, Executive Producer, Speaker and Breast Cancer Survivor Christine Handy to Raise Patient Awareness of Early-Stage Breast Cancer Treatment
• 16:51 Intensity Therapeutics stock hits 52-week low at $0.29
• 13:37 Benchmark maintains Speculative Buy on Intensity Therapeutics stock
• 16:18 Intensity stock rating cut to Hold by Brookline Capital
• 13:22 Why Intensity Therapeutics (INTS) Stock Is Getting Hammered - Intensity Therapeutics (NASDAQ:INTS)
• 14:21 Dow Jumps Over 1,000 Points; Tesla Shares Rise After Q1 Results - Charles & Colvard (NASDAQ:CTHR), AGM Gr Hldgs (NASDAQ:AGMH)